Page last updated: 2024-08-23

bromocriptine and amantadine

bromocriptine has been researched along with amantadine in 107 studies

Research

Studies (107)

Timeframe	Studies, this research(%)	All Research%
pre-1990	60 (56.07)	18.7374
1990's	21 (19.63)	18.2507
2000's	15 (14.02)	29.6817
2010's	10 (9.35)	24.3611
2020's	1 (0.93)	2.80

Authors

Authors	Studies
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Winkelman, AC	1
Hungerbühler, JP; Regli, F	1
Pöldinger, W	1
Przuntek, H	1
Hill, JW	1
Durand, JP; Gautier, JC	1
Agnoli, A; Casacchia, M; Ruggieri, S	1
Parkes, D	1
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E	1
Camanni, F; Isaia, GC; Massara, F; Molinatti, GM	1
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE	1
Suitsu, N	1
Morgan, MY	1
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F	1
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY	1
Borzecki, Z; Kaliszuk, S; Swies, Z	1
Nakashima, K; Takahashi, K	1
Onodera, K; Shinoda, H	1
Jacobs, MB; Varon, J	1
Gold, MS; Taylor, WA	1
Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V	1
Bar, M; Graff, E; Isakov, M; Oberman, Z; Rabey, JM; Scharf, M	1
Hippius, H; Spiess-Kiefer, C	1
Geber, J; Gjuris, V; Jagić, V; Krizanac, S; Mise, S; Petek, M; Rotkvić, I; Sikirić, P; Suchanek, E; Udovicić, I	1
Feather, JN; Folts, DJ; Giannini, AJ; Sullivan, BS	1
Lazarus, A	3
Harvey, NS	1
Munitz, H; Shalev, A	1
Huber, M	1
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA	1
Aminoff, MJ	1
Gawin, F; Kleber, H; Kosten, T; Morgan, C	1
Guerrero, RM; Shifrar, KA	1
Berman, ML; Tennant, F	1
Abbott, RJ; Loizou, LA	1
Sagherian, AA; Tennant, FS	1
Lakke, JP; Staal-Schreinemachers, AL	1
Muenter, MD	2
Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H	1
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J	1
Baxter, LR; Guzé, BH	1
Wirz, D	1
Addonizio, G; Susman, VL	1
Ciolino, C; Rosse, R	1
Grau-Veciana, JM; Peiró Grasa, A	1
Larsen, TA; Teräväinen, H	1
Weiner, M	1
Tegeler, J; Wöller, W	1
West, AP	1
Neppe, VM	1
Jörg, J	1
Biesemeyer, H; Ludin, HP; Ringwald, E	1
Alonso, RJ; Covington, TR; Mancall, EL	1
Morris, JG	2
Mattila, MJ; Nuotto, E	1
Fincke, M; Gothóni, P; Lehtinen, M	1
Veje, JO	1
Goetz, CG; Nausieda, PA; Tanner, CM	1
Boismare, F; Leclerc, JL; Moore, N; Saligaut, C	1
Stewart, RM	1
Danielczyk, W	1
Boada, JN; Feria, M; Padron, F	1
Bertha, G; Lechner, H; Ott, E	1
Janjua, R; Roos, RA; van Kempen, GM	1
Danysz, W; Quack, G; Rogoz, Z; Skuza, G	1
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O	1
Marken, PA; Schneiderhan, ME	1
Kornhuber, J; Weller, M	1
Kishore, A; Snow, BJ	1
Kuno, S	1
Geyer, MA; Oostwegel, JL; Randolph, E; Swerdlow, NR; Taaid, N	1
Burke, DT; Calvanio, R; Fitzpatrick, M; Karli, DC; Kim, HJ; Lepak, P; Macneil, M; Pesez, K; Temple, D	1
Sunohara, N	1
Farrell, M; Lima, MS; Reisser, AA; Soares, BG	2
Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR	1
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U	1
Auerbach, PP; Ross, L; Shoemaker, JM; Stephany, N; Swerdlow, NR; Talledo, J; Wasserman, LC	1
Reingardiene, D	1
Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD	1
Okamoto, K; Tanaka, M	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Elovic, EP; Napolitano, E; Qureshi, AI	1
Caroff, SN; Keck, PE; Strawn, JR	1
Farrell, M; Lima Reisser, AA; Silva de Lima, M; Soares, B	1
Aubut, JA; Bayley, M; Foley, N; Marshall, S; Megyesi, J; Meyer, MJ; Meythaler, J; Murie-Fernandez, M; Salter, K; Teasell, R	1
Duggan, C; Ferriter, M; Huband, N; Khalifa, N; Lieb, K; Stoffers, J; Völlm, BA	1
Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P	1
Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F	1
Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P	1
Majid, H; Zubair, UB	1
Cheung, NH; Gibbon, S; Khalifa, NR; McCarthy, L; Völlm, BA	1

Reviews

31 review(s) available for bromocriptine and amantadine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Considerations in the drug treatment of parkinsonism (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Nov-07, Volume: 67, Issue:45 Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor	1978
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints]. Medizinische Klinik, 1979, Jul-13, Volume: 74, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor	1979
Drug therapy: Bromocriptine. The New England journal of medicine, 1979, Oct-18, Volume: 301, Issue:16 Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin	1979
The treatment of chronic hepatic encephalopathy. Hepato-gastroenterology, 1991, Volume: 38, Issue:5 Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A	1991
Pharmacologic approaches to the treatment of cocaine dependence. The Western journal of medicine, 1990, Volume: 152, Issue:5 Topics: Amantadine; Antidepressive Agents, Tricyclic; Bromocriptine; Cocaine; Dopamine Agents; Humans; Substance-Related Disorders	1990
Neuroleptic malignant syndrome. Hospital & community psychiatry, 1989, Volume: 40, Issue:12 Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis	1989
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions. Psychosomatics, 1986, Volume: 27, Issue:3 Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception	1986
The neuroleptic malignant syndrome: agent and host interaction. Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4 Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome	1986
[Parkinson disease. The clinical picture and therapy]. Deutsche medizinische Wochenschrift (1946), 1988, Jun-16, Volume: 113, Issue:24 Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease	1988
Neuroleptic malignant syndrome. The British journal of psychiatry : the journal of mental science, 1986, Volume: 148 Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats	1986
Current concepts. Neuroleptic malignant syndrome. The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3 Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics	1985
Update on the treatment of Parkinson's disease. Connecticut medicine, 1985, Volume: 49, Issue:10 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors	1985
Update on antiparkinsonian agents. Geriatrics, 1982, Volume: 37, Issue:9 Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance	1982
The management of Parkinson's disease. Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:2 Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease	1982
Drug management of Parkinson's disease. Canadian family physician Medecin de famille canadien, 1996, Volume: 42 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl	1996
[Treatment of Parkinson's disease with multiple drugs]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide	1997
[Toxic and adverse neurological effects of anti-parkinsonian drugs]. Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders	1999
[Parkinson disease: diagnostic and therapeutic criteria]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus	2001
Dopamine agonists for cocaine dependence. The Cochrane database of systematic reviews, 2001, Issue:4 Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine; Humans; Randomized Controlled Trials as Topic	2001
[Neuroleptic malignant syndrome]. Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1 Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis	2002
Dopamine agonists for cocaine dependence. The Cochrane database of systematic reviews, 2003, Issue:2 Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine Agonists; Humans; Randomized Controlled Trials as Topic	2003
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury. Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:6 Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate	2005
Neuroleptic malignant syndrome. The American journal of psychiatry, 2007, Volume: 164, Issue:6 Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors	2007
WITHDRAWN: Dopamine agonists for cocaine dependence. The Cochrane database of systematic reviews, 2010, Feb-17, Issue:2 Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine Agonists; Humans; Randomized Controlled Trials as Topic	2010
Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma. Brain injury, 2010, Volume: 24, Issue:5 Topics: Amantadine; Arousal; Brain Injuries; Bromocriptine; Coma, Post-Head Injury; Dopamine Agonists; Evidence-Based Medicine; Humans; Levodopa; Music Therapy; Randomized Controlled Trials as Topic; Recovery of Function	2010
Pharmacological interventions for antisocial personality disorder. The Cochrane database of systematic reviews, 2010, Aug-04, Issue:8 Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Nortriptyline; Phenytoin; Psychotropic Drugs; Randomized Controlled Trials as Topic	2010
Dopamine agonists for the treatment of cocaine dependence. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic	2011
Dopamine agonists for the treatment of cocaine dependence. The Cochrane database of systematic reviews, 2015, May-27, Issue:5 Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias	2015
Pharmacological interventions for antisocial personality disorder. The Cochrane database of systematic reviews, 2020, 09-03, Volume: 9 Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Middle Aged; Nortriptyline; Phenytoin; Placebos; Psychotropic Drugs; Randomized Controlled Trials as Topic	2020

Trials

10 trial(s) available for bromocriptine and amantadine

Article	Year
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. International pharmacopsychiatry, 1978, Volume: 13, Issue:4 Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oxprenolol; Tremor	1978
[Treatment of parkinsonian syndromes by bromocriptin]. La Nouvelle presse medicale, 1977, Jan-22, Volume: 6, Issue:3 Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary	1977
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry. Pharmacology, 1978, Volume: 16 Suppl 1 Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents	1978
[Clinical experience with bromocriptine, a central dopaminergic stimulator]. Der Nervenarzt, 1976, Volume: 47, Issue:11 Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl	1976
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1992, Volume: 94, Issue:3 Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl	1992
Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. Digestive diseases and sciences, 1991, Volume: 36, Issue:7 Topics: Adult; Aged; Amantadine; Bromocriptine; Cimetidine; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Recurrence	1991
Bromocriptine and amantadine in cocaine detoxification. Psychiatry research, 1989, Volume: 29, Issue:1 Topics: Adult; Amantadine; Brain; Bromocriptine; Clinical Trials as Topic; Cocaine; Humans; Male; Random Allocation; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders	1989
A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence. NIDA research monograph, 1988, Volume: 81 Topics: Adult; Amantadine; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome	1988
Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Archives of internal medicine, 1987, Volume: 147, Issue:1 Topics: Adolescent; Adult; Amantadine; Ambulatory Care; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome	1987
Weekly drug holiday in Parkinson disease. Neurology, 1981, Volume: 31, Issue:11 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1981

Other Studies

66 other study(ies) available for bromocriptine and amantadine

Article	Year
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
Update on drug treatment of Parkinsonism. American family physician, 1977, Volume: 16, Issue:1 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1977
Drugs for Parkinson's disease. Lancet (London, England), 1978, Apr-08, Volume: 1, Issue:8067 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines	1978
In practice. Parkinson's disease. The New Zealand medical journal, 1979, Oct-10, Volume: 90, Issue:645 Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission	1979
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1979, May-04, Volume: 21, Issue:9 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1979
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects. Panminerva medica, 1975, Volume: 17, Issue:4 Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol	1975
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects. Neuroendocrinology, 1975, Volume: 19, Issue:3 Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil	1975
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases]. Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:1 Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia	1991
Drug treatment of the neuroleptic malignant syndrome. Psychopharmacology bulletin, 1991, Volume: 27, Issue:3 Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome	1991
The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 1990, Volume: 45 Topics: Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Male; Metoclopramide; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sulpiride	1990
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity. The Japanese journal of psychiatry and neurology, 1991, Volume: 45, Issue:4 Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl	1991
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons. Agents and actions, 1991, Volume: 33, Issue:1-2 Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl	1991
Treating the progressive stages of Parkinson's disease. Postgraduate medicine, 1991, Volume: 90, Issue:1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline	1991
Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease. Acta neurologica Scandinavica, 1990, Volume: 81, Issue:5 Topics: Administration, Oral; Aged; Amantadine; Biperiden; Bromocriptine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Piperidines	1990
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison]. Fortschritte der Neurologie-Psychiatrie, 1986, Volume: 54, Issue:5 Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk	1986
The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats. European journal of pharmacology, 1988, Mar-15, Volume: 147, Issue:3 Topics: Acute Disease; Amantadine; Amylases; Animals; Bromocriptine; Domperidone; Female; Male; Pancreas; Pancreatitis; Rats; Rats, Inbred F344; Receptors, Dopamine	1988
Comprehensive care of the patient with Parkinson's disease. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:3 Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor	1986
Parkinson's disease in the elderly: current management strategies. Geriatrics, 1987, Volume: 42, Issue:7 Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1987
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1988
Diagnosis and treatment of neuroleptic malignant syndrome. Clinical pharmacy, 1988, Volume: 7, Issue:9 Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome	1988
Stepwise detoxification from cocaine. A promising regimen. Postgraduate medicine, 1988, Volume: 84, Issue:2 Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine	1988
[Antiparkinson agents]. Nederlands tijdschrift voor geneeskunde, 1987, Feb-07, Volume: 131, Issue:6 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Lisuride; Parasympatholytics	1987
Therapy of neuroleptic malignant syndrome. Psychiatric developments, 1986,Spring, Volume: 4, Issue:1 Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine	1986
Pharmacotherapy: problems and practices. Clinical neuropharmacology, 1986, Volume: 9 Suppl 1 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
[Revision of the treatment strategy in Parkinson disease]. Nederlands tijdschrift voor geneeskunde, 1986, May-17, Volume: 130, Issue:20 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning	1986
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats. Acta neurologica Scandinavica, 1986, Volume: 74, Issue:4 Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats	1986
Assessing treatment of neuroleptic malignant syndrome. The American journal of psychiatry, 1986, Volume: 143, Issue:1 Topics: Amantadine; Bromocriptine; Cortisone; Drug Therapy, Combination; Humans; Neuroleptic Malignant Syndrome; Piperidines	1986
Dopamine agonists and neuroleptic malignant syndrome. The American journal of psychiatry, 1985, Volume: 142, Issue:2 Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome	1985
[Secondary effects of prolonged levodopa therapy in Parkinson's disease]. Medicina clinica, 1985, Jun-15, Volume: 85, Issue:3 Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1985
[Drug therapy of parkinsonism]. Duodecim; laaketieteellinen aikakauskirja, 1982, Volume: 98, Issue:11 Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease	1982
[Therapeutic measures in tardive dyskinesia]. Fortschritte der Neurologie-Psychiatrie, 1983, Volume: 51, Issue:6 Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid	1983
Treatments for neuroleptic malignant syndrome. The Journal of clinical psychiatry, 1984, Volume: 45, Issue:3 Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male	1984
The neuroleptic malignant syndrome. A priority system. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1984, Mar-31, Volume: 65, Issue:13 Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Consciousness Disorders; Dantrolene; Fever; Humans; Muscle Rigidity; Phenytoin; Syndrome	1984
Treating neuroleptic malignant syndrome. The American journal of psychiatry, 1984, Volume: 141, Issue:8 Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Muscle Rigidity	1984
[Therapeutic concept in Parkinson disease]. Deutsche medizinische Wochenschrift (1946), 1983, Jul-15, Volume: 108, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor	1983
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease. Journal of neurology, 1983, Volume: 230, Issue:1 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease	1983
Therapy of neurologic disorders in the elderly. Hospital practice (Office ed.), 1984, Volume: 19, Issue:10 Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl	1984
The drug treatment of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease	1984
Failure of amantadine and bromocriptine to counteract alcoholic inebriation in man. Acta pharmacologica et toxicologica, 1984, Volume: 55, Issue:3 Topics: Adult; Alcoholic Intoxication; Amantadine; Bromocriptine; Double-Blind Method; Humans; Kinetics; Male; Prolactin; Psychomotor Performance	1984
Drugs for Parkinson's disease reduce tremor induced by physostigmine. Naunyn-Schmiedeberg's archives of pharmacology, 1983, Volume: 323, Issue:3 Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor	1983
[Drug information: antiparkinson agents III. Amantadine (Symmetrel), bromocriptine (Parlodel)]. Sygeplejersken, 1981, Sep-30, Volume: 81, Issue:38 Topics: Amantadine; Antiparkinson Agents; Bromocriptine	1981
Initial treatment of Parkinson's disease. Clinical neuropharmacology, 1982, Volume: 5 Suppl 1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis	1982
Dopaminergic agonists and conditioned avoidance response in normoxic or hypoxic rats. Aviation, space, and environmental medicine, 1981, Volume: 52, Issue:1 Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Bromocriptine; Dopamine; Female; Hypoxia; Piribedil; Rats	1981
Parkinson's disease: new treatments. Comprehensive therapy, 1981, Volume: 7, Issue:4 Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus	1981
[Crises in the course of Parkinson's disease]. Wiener medizinische Wochenschrift (1946), 1980, Feb-29, Volume: 130, Issue:4 Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders	1980
Respiratory effects of amantadine and bromocriptine and their interaction with haloperidol in anesthetized rats. Il Farmaco; edizione scientifica, 1980, Volume: 35, Issue:7 Topics: Amantadine; Anesthesia; Animals; Bromocriptine; Drug Interactions; Haloperidol; Male; Rats; Respiration; Time Factors	1980
[Current treatment of Parkinsonian syndrome]. Die Medizinische Welt, 1980, Volume: 31, Issue:40 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease, Secondary	1980
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease. Clinical neurology and neurosurgery, 1995, Volume: 97, Issue:2 Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome	1995
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. Journal of neural transmission. General section, 1994, Volume: 98, Issue:1 Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline	1994
Day-night variation of urine volume in Parkinson's disease. The Japanese journal of psychiatry and neurology, 1994, Volume: 48, Issue:3 Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine	1994
An atypical course of neuroleptic malignant syndrome. Journal of clinical pharmacology, 1994, Volume: 34, Issue:4 Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors	1994
Amantadine withdrawal and neuroleptic malignant syndrome. Neurology, 1993, Volume: 43, Issue:10 Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	1993
Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural pharmacology, 1998, Volume: 9, Issue:5-6 Topics: Acoustic Stimulation; Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Interactions; Humans; Indoles; Male; Pergolide; Rats; Rats, Sprague-Dawley; Reflex, Startle; Species Specificity	1998
Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain injury, 1999, Volume: 13, Issue:1 Topics: Accidental Falls; Adult; Akathisia, Drug-Induced; Amantadine; Brain Injuries; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Frontal Lobe; Hallucinations; Humans	1999
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology, 2002, Volume: 161, Issue:2 Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors	2002
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea. Journal of the National Medical Association, 2002, Volume: 94, Issue:4 Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema	2002
Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology, 2002, Volume: 164, Issue:1 Topics: Acoustic Stimulation; Adult; Amantadine; Analysis of Variance; Animals; Bromocriptine; Dose-Response Relationship, Drug; Humans; Male; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reflex, Startle; Species Specificity	2002
The use of dopamine enhancing medications with children in low response states following brain injury. Brain injury, 2003, Volume: 17, Issue:6 Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness	2003
[Therapy for patients with early-stage Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl	2003
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice. Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:2 Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase	2013
Anti-NMDA Receptor Encephalitis in a Young Girl with Altered Behaviour and Abnormal Movements. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:8 Topics: Adolescent; Amantadine; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Bromocriptine; Dyskinesias; Female; Humans; Leukocytosis; Methylprednisolone; Nervous System Diseases; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2018